<p>Rami Manochakian, M.D., a thoracic clinical oncologist at the Mayo Clinic in Florida, presents information on the recently approved drug in oncology, durvalumab for patients with stage III Non-Small Cell Lung Cancers (NSCLC) after the completion of radiation therapy.</p>

Rami Manochakian, M.D., a thoracic clinical oncologist at the Mayo Clinic in Florida, presents information on the recently approved drug in oncology, durvalumab for patients with stage III Non-Small Cell Lung Cancers (NSCLC) after the completion of radiation therapy.

Recently Approved Drugs: Durvalumab for patients with stage III Non-Small Cell Lung Cancers (NSCLC)

ASCO Education: By the Book features engaging discussions between editors and authors from the ASCO Educational Book.  Hear nuanced views on topics featured in Education Sessions at ASCO meetings and deep dives on the approaches shaping modern oncology that have care teams talking.

Medicine

Health & Fitness

ASCO Education: By the Book features engaging discussions between editors and authors from the ASCO Educational Book. Hear nuanced views on topics featured in Education Sessions at ASCO meetings and deep dives on the approaches shaping modern oncology that have care teams talking.

Share Recently Approved Drugs: Durvalumab for patients with stage III Non-Small Cell Lung Cancers (NSCLC)

Sign up to save your podcasts

Recently Approved Drugs: Durvalumab for patients with stage III Non-Small Cell Lung Cancers (NSCLC)

Recently Approved Drugs: Durvalumab for patients with stage III Non-Small Cell Lung Cancers (NSCLC)

More shows like ASCO Education

NEJM This Week

Journal of Clinical Oncology (JCO) Podcast

JCO Oncology Practice Podcast

ASCO Daily News

The Curbsiders Internal Medicine Podcast

ASCO Guidelines

The Readout Loud

OncLive® On Air

Money Meets Medicine

Oncology Today with Dr Neil Love

The Foreign Affairs Interview

Not Otherwise Specified

Two Onc Docs

Oncology Brothers: Practice-Changing Cancer Discussions

The Best People with Nicolle Wallace